Our results suggest that imeglimin mitigates the accumulation of dysfunctional mitochondria in β-cells from db/db mice, leading to an increase in the amount of secreted insulin, suppression of apoptotic β-cell death and amelioration of hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.